This report studies the Global Live Cell Imaging market, with an emphasis on North America, Europe, China, Japan, Southeast Asia and India. It focuses on top manufacturers in the industry, detailing their production capacity, price competition and revenue generated.
This report studies the global live cell imaging market for the forecast period of 2017 to 2022. This market is expected to reach $5.45 Billion by 2019 from $5.57 Billion in 2016, at a CAGR of 12.8% during the forecast period (2016 to 2022).
Factors driving this market include adoption of high-content screening techniques in drug discovery, rising incidence of cancer worldwide, and government funding in cell-based research. However, factors such as high cost of high-content screening systems and shortage of knowledgeable and skilled professionals are hindering the growth of this market.
Some of the major players in the global live cell imaging market include Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific, Inc.
Download Sample Pages @ www.kminsights.com/request-sample-…tm_medium=Chhagan
Category: Market Research Publishers and RetailersCompany profile: Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns. Our online stage, KMInsights.com, offers an unmatched gathering of market examination reports, organization audits, databooks, articles, periodical distributions, databases, on-line endorser administrations, and a great deal m ...
For more information:Make an Inquiry about this report HERE!